BioSyent Inc. (BIOYF)
OTCMKTS · Delayed Price · Currency is USD
7.64
-0.14 (-1.80%)
Nov 12, 2025, 4:00 PM EST
BioSyent Market Cap
BioSyent has a market cap or net worth of $86.13 million as of November 12, 2025. Its market cap has decreased by -4.82% in one year.
Market Cap
86.13M
Enterprise Value
72.26M
Revenue
28.97M
Ranking
n/a
PE Ratio
14.22
Stock Price
$7.64
Market Cap Chart
Since April 24, 1997, BioSyent's market cap has increased from 9.48M to 86.13M, an increase of 808.39%. That is a compound annual growth rate of 8.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 12, 2025 | 86.13M | -2.95% |
| Dec 31, 2024 | 88.75M | 8.08% |
| Dec 29, 2023 | 82.11M | 31.23% |
| Dec 30, 2022 | 62.57M | -23.01% |
| Dec 30, 2021 | 81.27M | 2.23% |
| Dec 31, 2020 | 79.49M | 24.45% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 815.80M |
| Elite Pharmaceuticals | 693.46M |
| Glass House Brands | 583.42M |
| American Oncology Network | 371.75M |
| Northwest Biotherapeutics | 367.30M |
| Silence Therapeutics | 317.41M |
| Nika Pharmaceuticals | 311.89M |
| CytoDyn | 308.39M |